The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...

The Sackler family and Purdue Pharma have agreed to a combined $7.4 billion settlement, according to the Utah Department of Commerce. Utah’s share would be $57 million of it if the state agrees ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, represents ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and other states said.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

If one is not reached, it could open the floodgates to lawsuits against Sackler family members.The new settlement could bring to a close a chapter in a long legal saga over the toll of an opioid ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...